Skip to main content
. 2019 Jun 11;11:118–128. doi: 10.1016/j.ijpddr.2019.05.003

Figure 3.

Figure 3

Figure 3

Screening of secondary fractions of the 8 active primary fractions (two from HDLSX-9, and one each from HDLSX-21, 22, 35, 127, 159, 171) against axenic amastigote L. mexicana at 1 mg/ml x-axis shows the secondary fractions from the following primary extract fractions: A HDLSX9 fractions 9 and 10 (HDLSX9Fr9+10); B HDLSX9 fraction 13 (HDLSX9Fr13); C HDLSX21 fraction 1 (HDLSX21Fr1); D HDLSX22 fractions 13 and 14 (HDLSX22Fr13 + 14); E HDLSX35 fraction 17 (HDLSX35Fr17); F HDLSX159 fractions 12 and 13 (HDLSX159Fr12 + 13); G HDLSX127 fraction 11 (HDLSX127Fr11); H HDLSX171 fraction 7 (HDLSX171Fr7). y-axis shows proliferation (%) relative to vehicle (DMSO) treated control.